{
  "entities": {
    "activities": {
      "f8b7fedf-0217-43e6-9cf5-51298dcaa6f1": "Apheresis",
      "cf0436ad-d78c-4567-aabf-f2328123e859": "Blood Sampling",
      "545c213e-c9c2-4c9e-a6ff-d7fd7ff55333": "Chest Radiograph",
      "321cf012-e7f5-43eb-82db-67eb340059f0": "Clinical remission and not receiving concomitant corticosteroids at Week 44",
      "fedbe3f4-e9fc-41fe-af0d-0b1d59c495b1": "Electrocardiogram",
      "3c38e22c-906c-4f14-8bd0-4c1620cb97f4": "Endoscopic healing at Week 44",
      "36277c9b-cf03-4dcb-a05a-27144feb02bc": "Endoscopy",
      "ba3d34fa-1f60-4276-a61c-d3cb0b4cfbfd": "Fecal Sample Collection",
      "d086f63a-2bc1-455f-9277-580a59ed795a": "Intravenous Infusion",
      "d5dbfddb-509e-41f2-8992-bc0fb7e16313": "Maintenance of clinical remission through Week 44 among the subjects who had achieved clinical remission at maintenance baseline (both global and US definitions)",
      "c9e32b2d-3aa2-487d-84fb-c7bbdd7c5fb9": "Maintenance of clinical response through Week 44",
      "d52f5366-b6d8-4d62-96a2-2bbbc8b53387": "Mucosal Biopsy",
      "029c8679-8096-4081-b451-8f579b882c32": "Physical Examination",
      "58669f1b-cd86-44b3-a8db-bc892dc609f9": "QuantiFERON-TB Gold Test",
      "945f2ef3-4840-4734-890a-5493d31e6549": "Subcutaneous Injection",
      "98ad1374-7269-4360-a15e-75af3e8f607e": "Tuberculin Skin Test",
      "1b4ca360-9d55-427e-ab3f-1226171061af": "Vital Signs Monitoring"
    },
    "plannedTimepoints": {},
    "encounters": {
      "56c32db4-4f8e-42d2-8547-7b2942888f99": "Placebo SC",
      "483f2f38-87fa-4ad9-9461-cc48723c3cee": "Ustekinumab 90 mg SC q12w",
      "1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": "Ustekinumab 90 mg SC q8w"
    },
    "epochs": {
      "653b7227-8f90-4fb0-a2a8-68d5921a498d": "Maintenance Study"
    },
    "activityGroups": {}
  },
  "cells": {
    "c9e32b2d-3aa2-487d-84fb-c7bbdd7c5fb9|56c32db4-4f8e-42d2-8547-7b2942888f99": "both",
    "c9e32b2d-3aa2-487d-84fb-c7bbdd7c5fb9|483f2f38-87fa-4ad9-9461-cc48723c3cee": "both",
    "c9e32b2d-3aa2-487d-84fb-c7bbdd7c5fb9|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": "both",
    "3c38e22c-906c-4f14-8bd0-4c1620cb97f4|56c32db4-4f8e-42d2-8547-7b2942888f99": "both",
    "3c38e22c-906c-4f14-8bd0-4c1620cb97f4|483f2f38-87fa-4ad9-9461-cc48723c3cee": "both",
    "3c38e22c-906c-4f14-8bd0-4c1620cb97f4|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": "both",
    "321cf012-e7f5-43eb-82db-67eb340059f0|56c32db4-4f8e-42d2-8547-7b2942888f99": "both",
    "321cf012-e7f5-43eb-82db-67eb340059f0|483f2f38-87fa-4ad9-9461-cc48723c3cee": "both",
    "321cf012-e7f5-43eb-82db-67eb340059f0|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": "both",
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|56c32db4-4f8e-42d2-8547-7b2942888f99": "both",
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|483f2f38-87fa-4ad9-9461-cc48723c3cee": "both",
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": "both"
  },
  "cellFootnotes": {
    "c9e32b2d-3aa2-487d-84fb-c7bbdd7c5fb9|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": [
      "a"
    ],
    "3c38e22c-906c-4f14-8bd0-4c1620cb97f4|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": [
      "a"
    ],
    "321cf012-e7f5-43eb-82db-67eb340059f0|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": [
      "a"
    ],
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|56c32db4-4f8e-42d2-8547-7b2942888f99": [
      "b"
    ],
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|483f2f38-87fa-4ad9-9461-cc48723c3cee": [
      "b"
    ],
    "d5dbfddb-509e-41f2-8992-bc0fb7e16313|1d032bb4-3bdd-40cc-89e5-fa0ce370a86e": [
      "a",
      "b"
    ]
  },
  "metadata": {
    "model": "gemini-3-flash-preview",
    "extraction_type": "text"
  }
}